Cystic Fibrosis Market

Dec 08, 2020

10 likes | 17 Views

Cystic Fibrosis is a life-limiting autosomal recessive genetic disorder that severely damages the lungs and the digestive system. As per the Delveinsight, the total prevalent population of Cystic Fibrosis in 6MM was 61,306 in 2017. The prevalent population of Cystic Fibrosis in the UK was 10,468, while the US and Spain had a prevalent population of 30,139 and 2,075 respectively in 2017. The Cystic Fibrosis market Size in the 6MM was found to be USD 1,940.1 million in 2017. High number of drugs in the pipeline, better diagnostic techniques, most frequent mutation, and increased Research Funding are some of the key factors expected to drive the Cystic Fibrosis market forward in the coming years. Some of the key companies in the Cystic Fibrosis market include Translate Bio, Proteostasis Therapeutics, Vertex Pharmaceuticals, Arrowhead Pharmaceuticals, ProQR Therapeutics, Ionis Pharmaceuticals, Verona Pharmaceuticals, Eloxx Pharmaceuticals, and many others. For more details, visit: https://www.delveinsight.com/report-store/cystic-fibrosis-market Source : Cystic Fibrosis Market Analysis

DelveInsight

Download Presentation

Cystic Fibrosis Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D